Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

STO/DICOT stock hub

STO/DICOT has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

STO/DICOTis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

526.8M

Nasdaq Stockholm

Market data

Live price

Current market quote for this ticker.

Current price

STO/DICOT

In the news

Latest news · STO/DICOT

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-98.2

P25 n/aP50 n/aP75 n/a

ROIC-63.1

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All STO/DICOT market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

127

Groups with data

Currency

SEK

Showing 127 of 127 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Sweden
Country code	SE
Employees	4
Employees Change	1%
Employees Change Percent	33.33
Enterprise value	SEK 470.6M
Exchange	Nasdaq Stockholm
Financial currency	SEK
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Last refreshed	2026-05-10
Market cap	SEK 526.8M
Price	SEK 0.26
Price currency	SEK
Sector	Healthcare
Sic	2834
Symbol	sto/DICOT
Website	https://www.dicotpharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-13.69%
EV Earnings	-6.52x
P/B ratio	9.01x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	SEK -72.1M
Profit Per Employee	SEK -18M
ROA	-53.43
Roa5y	-66.09
ROCE	-126.7
ROE	-98.21
Roe5y	-128
ROIC	-63.07

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-21.51%
Cagr3y	7.85%
Cagr5y	-25.93%

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	SEK 70.9M
Cash	SEK 56.2M
Current Assets	SEK 70.9M
Current Liabilities	SEK 12.4M
Equity	SEK 58.5M
Interest Coverage	-12,353.7
Liabilities	SEK 12.4M
Long Term Assets	SEK 0
Long Term Liabilities	SEK 0
Net Cash	SEK 56.2M
Net Cash By Market Cap	SEK 10.67
Net Cash Growth	-39.44%
Net Debt Equity	SEK -0.96
Tangible Book Value	SEK 58.5M
WACC	9.23

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	5.72
Net Working Capital	SEK 2.3M
Quick ratio	4.97
Working Capital	SEK 58.5M

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-21.5%
200-day SMA	0.52
3Y total return	25.46%
50-day SMA	0.36
50-day SMA vs 200-day SMA	50under200
5Y total return	-77.7%
All Time High	11.5
All Time High Change	-97.72%
All Time High Date	2018-06-27
All Time Low	0.1
All Time Low Change	173.13%
All Time Low Date	2023-11-13
ATR	0.03
Beta	0.91
Beta1y	-0.9
Beta2y	-0.96
Ch YTD	-14.59
High	0.27
High52	1.18
High52 Date	2025-10-23
High52ch	-77.78%
Low	0.26
Low52	0.24
Low52 Date	2026-04-28
Low52ch	8.44%
Ma50ch	-27.73%
Price vs 200-day SMA	-49.36%
RSI	26.54
RSI Monthly	43.72
RSI Weekly	38.36
Sharpe ratio	0.32x
Sortino ratio	0.52
Tr YTD	-14.59
Tr1m	-34.42%
Tr1w	-7.35%
Tr3m	-20.3%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	SEK -74.1M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1,703,910,145%
Shares Insiders	11.3%
Shares Institutions	11.09%
Shares Out	2,009,342,502

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	9,800,620x
Ch1m	-34.42
Ch1w	-7.35
Ch1y	-21.5
Ch3m	-20.3
Ch3y	25.46
Ch5y	-77.7
Ch6m	-35.1
Change	-1.06%
Change From Open	-2.31
Close	0.27
Days Gap	1.28
Dollar Volume	2,820,587.7
Earnings Date	2026-04-30
EBIT	SEK -74.1M
F Score	0
Financing CF	41,823,000
Fiscal Year End	December
Founded	2,015
Is Primary Listing	1
Last Earnings Date	2026-04-30
Last Report Date	2026-03-31
Ma150	0.42
Ma150ch	-38.2%
Ma20	0.35
Ma20ch	-24.15%
Net CF	-36,630,000
Next Earnings Date	2026-08-07
Open	0.27
Position In Range	2
Price Date	2026-05-08
Ptbv Ratio	9.01
Relative Volume	1.1x
Tr6m	-35.1%
Volume	10,757,390

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does STO/DICOT pay a dividend?

Capital-return profile for this ticker.

Performance

STO/DICOT stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns STO/DICOT?

Insider, institutional, and short-interest positioning.

Institutional ownership

+11.1%

Share of float held by funds and institutions

Insider ownership

+11.3%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

STO/DICOT momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

26.5

Below 30: short-term oversold

Price vs 200-day MA

-49.4%

50/200-day relationship not available

Beta (5Y)

0.91

Moves roughly with the market

Sharpe ratio

0.32

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About STO/DICOT

Hub-level FAQ points readers to the deeper analysis pages.

What is the current sto/DICOT stock rating?

sto/DICOT is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full sto/DICOT analysis?

The full report lives at /stocks/sto/DICOT/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for sto/DICOT?

The latest report frames sto/DICOT around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the sto/DICOT page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.